TL;DR: Fathers experience a protective period early postpartum (depression drops by 26%), but depression and stress surge at months 10-11, creating a 30-36% elevated risk when no one is screening for it. Perinatal psychiatry has a crisis of attention. Mothers are screened relentlessly. Fathers are largely invisible. Yet a groundbreaking Swedish national study reveals something …
TL;DR: Untreated depression increases miscarriage risk by 34% across nearly 9 million women, but antidepressants reduce that risk to 24%—meaning the medication is safer than the disease during pregnancy. For decades, obstetricians have asked the wrong question about depression in pregnancy. They worried: Is the antidepressant dangerous? New data suggests a more sobering reality—the untreated …
TL;DR: Using PET imaging to directly visualize AMPA receptors in the living human brain, researchers discovered that ketamine’s rapid antidepressant effect works by reshuffling these receptors across specific brain regions in patients with treatment-resistant depression — and where they go predicts who will respond to the drug. Nearly one in three people with depression fail …
TL;DR: Blocking DUSP6 protein alongside ketamine extends antidepressant effects from 2 weeks to 4+ weeks in mice, potentially offering single-dose treatment instead of repeated infusions. Ketamine works like almost nothing else in psychiatry. A single infusion can lift severe depression within hours, even in patients who’ve failed every other drug. The problem? The magic doesn’t …
TL;DR: Young adults with depression produce ATP—the cell’s energy currency—at faster rates in both brain and blood, yet still feel more fatigued. New research reveals this is a compensatory mechanism that works at rest but collapses under stress, opening a fresh window into the biology of depression-related fatigue. Fatigue in major depression is relentless and …
TL;DR: Aerobic exercise matches antidepressant efficacy for depression with effect size −1.60, resistance training slightly edges aerobic for anxiety, and neither requires meeting WHO guidelines—20 minutes three times weekly still produces clinical improvement. Depression responds to a treatment that’s free, legal, and accessible: exercise. But the type matters profoundly. A comprehensive meta-analysis of 26 randomized …
TL;DR: Chemists designed a new psilocin derivative with fluorine modifications that induces sub-hallucinogenic effects in mice, sidestepping the acute psychological effects of classic psychedelics while retaining therapeutic serotonin receptor activity. Psilocybin has emerged as a clinical darling—mounting evidence shows rapid relief for depression, anxiety, and cluster headaches. But there’s a catch: the intense hallucinations and …
TL;DR: Chronic insomnia fragments REM sleep through persistent hyperarousal, preventing emotional memory consolidation and creating a vicious cycle that breeds depression—but cognitive-behavioral therapy for insomnia can break the cycle faster than antidepressants alone. Insomnia has a hidden mechanism. You lie awake for hours, but the real problem isn’t the wakefulness—it’s what happens to REM sleep, …
TL;DR: Obesity and depression form a pathophysiological trap: inflammatory cytokines and dysbiotic bacteria from obesity trigger neuroinflammation and mood disruption, while depression’s behavioral changes and HPA axis dysfunction worsen obesity. Obesity and depression are twin epidemics in the modern world, and they’re not independent. People with obesity are 1.5 to 2 times more likely to …
TL;DR: Diabetes and depression form a vicious cycle: high blood sugar triggers neuroinflammation and HPA axis dysfunction that cause depression, while depression sabotages blood sugar control through behavioral and metabolic pathways. Doctors have known for years that depression and type 2 diabetes often occur together. A patient in the clinic with uncontrolled blood sugar frequently …
